“MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)” (2013) Mediterranean Journal of Hematology and Infectious Diseases, 6(1), p. e2014009. doi:10.4084/mjhid.2014.009.